Aurobindo Pharma and Intas are in the race to buy UK-based Mallinckrodt’s generic drugs business in the US valued at USD 2
Britain’s top share index edged higher on Thursday, boosted by rises in pharmaceutical and mining stocks, while retailers were also in favour